RecruitingNot ApplicableNCT07505082

Nectero EAST System Retreatment Study

A Clinical Pilot Study to Evaluate the Safety and Clinical Utility of Retreatment With the Nectero EAST System for Stabilization of Abdominal Aortic Aneurysms

Sponsor

Nectero Medical, Inc.

Enrollment

10 participants

Start Date

Mar 3, 2026

Study Type

INTERVENTIONAL

Conditions

AAA - Abdominal Aortic Aneurysm Aorta Aneurysm Dilation Aorta

Summary

This is an exploratory pilot study to evaluate the safety and clinical utility of retreatment with an investigational combination product called the Nectero EAST System to treat Abdominal Aortic Aneurysms or AAA.

Eligibility

Min Age: 21 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Nectero EAST System for people with aaa - abdominal aortic aneurysm, aorta aneurysm, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 21 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTNectero EAST System

Participants will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product.